BrainStorm Cell Therapeutics

BrainStorm Gears Up for Phase IIIb NurOwn Trial Amidst ALS Malaise
BioSpace
Mon, 07/22/24 - 11:29 am
BrainStorm Cell Therapeutics
FDA
ALX
NurOwn
stem cells
FDA gives nod to BrainStorm for ALS trial after Phase III flop
Clinical Trials Arena
Tue, 04/9/24 - 11:39 am
BrainStorm Cell Therapeutics
clinical trials
NurOwn
FDA
ALS
BrainStorm lays off 30% of staff, slimming down for yet another bid to get ALS cell therapy to market
Fierce Biotech
Tue, 10/24/23 - 09:53 am
BrainStorm Cell Therapeutics
layoffs
FDA
ALS
NurOwn
BrainStorm eyes FDA meeting to find path for rejected ALS drug after withdrawing application
Fierce Biotech
Wed, 10/18/23 - 11:20 am
BrainStorm Cell Therapeutics
ALS
FDA
NurOwn
Path for BrainStorm ALS Treatment Remains Rocky, Hope for Others on Horizon
BioSpace
Sun, 10/1/23 - 01:05 pm
FDA
BrainStorm Cell Therapeutics
NurOwn
Seelos Therapeutics
Takeda
Clene
FDA Adcomm Rejects BrainStorm’s ALS Therapy in Nearly Unanimous Vote
BioSpace
Wed, 09/27/23 - 11:21 pm
BrainStorm Cell Therapeutics
FDA
ALS
NurOwn
Companies to Watch: 12 Late-Stage Contenders in Neurodegenerative Disease
BioSpace
Mon, 07/24/23 - 09:57 am
neurodegenerative disease
Alzheimer's disease
Axsome Therapeutics
Eli Lilly
Anavex
TauRx
AB Science
ALS
BrainStorm Cell Therapeutics
Seelos Therapeutics
Parkinson's Disease
AbbVie
Mitsubishi Tanabe Pharma
Annovis
Huntington's disease
Prilenia Therapeutics
Neurocrine
Following in Biogen's wake, BrainStorm analyzes effect of ALS cell therapy on biomarker
Fierce Biotech
Fri, 07/7/23 - 08:40 am
BrainStorm Cell Therapeutics
ALS
cell therapy
Biogen
NurOwn
9 Highly Anticipated FDA Decisions in Second Half of 2023
BioSpace
Fri, 06/30/23 - 11:52 am
FDA
Eisai
Biogen
Leqembi
Alzheimer's disease
SAGE Therapeutics
zuranolone
postpartum depression
major depressive disorder
Roche
Tecentriq
non-small cell lung cancer
CRISPR Therapeutics
Bluebird Bio
lovo-cel
exa-cel
BrainStorm Cell Therapeutics
NurOwn
FDA sets advisory meeting date for Brainstorm’s ALS cell therapy
BioPharma Dive
Tue, 06/6/23 - 04:11 pm
BrainStorm Cell Therapeutics
FDA
NurOwn
cell therapy
ALS
BrainStorm Secures FDA Adcomm for ALS Therapy NurOwn
BioSpace
Mon, 03/27/23 - 10:08 am
BrainStorm Cell Therapeutics
NurOwn
ALS
FDA
BrainStorm Vows to Push for Adcomm Meeting on NurOwn in ALS
BioSpace
Mon, 11/14/22 - 10:53 am
BrainStorm Cell Therapeutics
NurOwn
ALS
FDA
Not once, but twice: BrainStorm shares tumble as FDA again knocks back ALS drug
Fierce Biotech
Thu, 11/10/22 - 10:32 am
BrainStorm Cell Therapeutics
ALS
FDA
NurOwn
BrainStorm Brings MS Data on Heels of ALS BLA Announcement
BioSpace
Fri, 09/16/22 - 10:19 am
BrainStorm Cell Therapeutics
NurOwn
multiple sclerosis
MS
Highlighted by Amylyx, the ALS Space is Gaining Momentum
BioSpace
Fri, 09/9/22 - 11:11 am
ALS
AMX0035
Amylyx
GeNeuro
NeuroSense Therapeutics
BrainStorm Cell Therapeutics
BrainStorm’s ALS Drug Heads to the FDA with Correction to Phase III Analyses
BioSpace
Mon, 08/15/22 - 10:17 am
BrainStorm Cell Therapeutics
NurOwn
ALS
FDA
clinical trials
NurOwn: A Study in the Complexity of ALS Trials
BioSpace
Tue, 05/4/21 - 10:44 pm
BrainStorm Cell Therapeutics
NurOwn
ALS
clinical trials
BrainStorm Trial Shows Promising Top-Line Results for Progressive Multiple Sclerosis
BioSpace
Wed, 03/24/21 - 11:15 pm
BrainStorm Cell Therapeutics
MS
clinical trials
multiple sclerosis
FDA calls out Brainstorm’s ALS stem cell therapy, says data don’t show benefit
MedCity News
Thu, 03/4/21 - 09:53 am
BrainStorm Cell Therapeutics
ALS
stem cell therapy
clinical trials
FDA
Despite red flag from FDA, controversial ALS cell therapy developer says it may still march ahead anyway
Endpoints
Mon, 02/22/21 - 10:51 am
BrainStorm Cell Therapeutics
ALS
cell therapy
FDA

Pages